Bristol-Myers (BMY)
- Analysts are citing a positive readacross to Bristol-Myers from positive results for Bayer's experimental stroke-prevention drug
- Cantor: Bayer’s data supports confidence in BMY’s own program in secondary stroke prevention
- Earlier this month: shares fell after one of its most important experimental medicines appeared unlikely to benefit patients who had suffered a heart complication, another setback for the drugmaker’s product pipeline
Cooper (COO)
- Maker of medical devices and surgical instruments;
- Activist investors Browning West wrote a letter to the board saying its “inadequate” oversight has led the company to significantly underperform and miss financial guidance
- Calls for urgent change at the Board to refocus the co. and appoint Browning West’s director candidates
- Urges Cooper to pause any potential restructuring efforts until Browning West’s recommended directors are seated so that any restructuring is optimized in scope and magnitude
- Reuters reported earlier this month that Browning West owns about 4% of Cooper
WBD
- Netflix, Comcast and Paramount Skydance all submitted bids for Warner Bros. Discovery by the Nov. 20 deadline for a first bid
- Comcast and Netflix are most interested in the film and TV library; Paramount is willing to buy the whole company
- Fourth owner in seven years
- Warner Bros. may not reach a deal with any of the suitors and may continue its current plan to separate its flagging cable networks from the rest of the businesses next year
See omnystudio.com/listener for privacy information.
